Abstract
We have used a recombinant adenovirus vector (E1−) expressing β-galactosidase to explore a novel mechanism with which to transfer genes into cells of the central nervous system (CNS). The replication-deficient adenovirus vector expressing β-galactosidase (RAd35) was propagated on a permissive helper cell line (293 cells). High level protein expression from the human cytomegalovirus immediate early promoter (hCMV IE) was obtained in a target cell population of RAd35 infected cultured neuronal and glial cell lines. Light microscopy showed that over 50% of the glial cells studied expressed β-galactosidase. Following retinoic acid treatment, RAd35 infected cell lines ND7/23, NG108 and NTera2, showed β-galactosidase expression in up to 90% of the cells. In addition, these cells showed morphological evidence of differentiation into neurons. This pattern of β-galactosidase expression was also observed in primary rat cerebella granule neuron cultures. In vivo studies were performed in Balb/c mice following direct intracranial injections of RAd35 into the brain. Cell sections showed a localised staining in the brain at the site of injection of the virus. Non-replicating adenovirus vectors are therefore highly efficient systems for delivering a transgene into brain cells. However, their broad cell tropism may limit their applications for genetic disorders in which a specific cell type is to be targeted for gene therapy. To address this problem, we have constructed adenovirus vectors which contain specific neuronal promoters and are currently assessing in vitro expression.
Similar content being viewed by others
References
Akli S, Calliaud C, Vigne E, Stratford-Perricaudet LD, Poenaru L, Perricaudet M, Kahn A and Peschanski MR (1993) Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genetics 3: 224–228.
Badie B, Hunt K, Economou JS and Black KL (1994) Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model. Neurosurgery 35: 910–916.
Blair GE, Proffitt JL and Blair-Zajdel ME (1995) Modulation of MHC class I antigen expression in adenovirus infection and transformation. In: Blair GE, Pringle CS and Mandsley JR (eds) Modulation of MHC antigen expression and disease. Cambridge University Press, 192–232.
Brody SL, Jaffe HA, Han SK, Wersto RP and Crystal RG (1994) Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors. Human Gene Therapy 5: 437–447.
Caillaud C, Akli S, Vigne E, Koulakoff A, Perricaudet M, Poenaru L, Kahn A and Berwld Netter Y (1993) Adenoviral vector as gene delivery system into cultured rat neuronal and glial cells. European Journal of Neuroscience 5: 1287–1291.
Cotte CA, Ragavan D, Mc Ilhinney RA and Monaghan P (1982) Characterisation of a new human cell line derived from a xenografted embryonal carcinoma. In Vitro 18: 739–750.
Fooks AR, Schadeck E, Liebert UG, Dowsett AB, Rima BK, Steward M, Stephenson JR and Wilkinson GWG (1995) High level expression of the measles virus nucleocapsid protein by using a replication deficient adenovirus vector: Induction of an MHC-1-restricted CTL response and protection in a murine model. Virology 210: 456–465.
Ginsberg, H (1996) The ups and downs of adenovirus vectors. Bulletin of the New York Academy of Medicine 73: 53–58.
Kozak CA (1985) Susceptibility of wild mouse cells to exogenous infection with xenotropic leukemia viruses: control by a single dominant locus on chromosome I. J. Virology 55: 690–695.
Lampson LA (1987) Molecular basis of the immune response to neural antigens. Trends Neuroscience 10: 211–216.
Lowenstein PR, Wilkinson GWG, Castro, MG, Shering AF, Fooks AR and Bain D (1996) Non-neurotropic adenovirus: a vector for gene transfer to the brain and possible gene therapy of neurological disorders. In: DS Latchman (ed) Genetic Manipulation of the Nervous System, Neuroscience Perspectives Series, pp. 11–32, Academic Press, London, UK.
Pleasure SJ and Lee VMY (1993) NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J. Neuroscience Res. 35, 585–602.
Randrianarison-Jewtoukoff V and Perricaudet M (1995) Recombinant adenoviruses as vaccines. Biologicals 23: 145–157.
Rubin BA and Rorke LB (1994) Adenovirus vaccines. In: SA Poltkin and EA Mortimer Jr. (eds) Vaccines, pp. 475–501, Philadelphia.
Rosenfield MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Dalemans W, Fukayama M, Bargon J, Stier LE, Stratford-Perricaudet L, Perricaudet M, Guggino WB, Pavirani A, Lecocq JP and Crystal RG (1992) In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68: 143–155.
Sivasubramaniam SD, Fooks AR, Lee J, Stacey G and Jennings AD (1997) Neurological therapy — Adenovirus mediated gene therapy in cells of the central nervous system. From Vaccines to Genetic Medicine, M Carrando, JB Griffiths and GL Moreira (eds) ESACT 14, Kluwer Academic Publishers, The Netherlands, pp. 51–56.
Tripathy SK, Black HB, Wasser E and Leiden JM (1996) Immune responses to transgene-encoded protein limit the stability of gene expression after injection of replication-deficient adenovirus vector. Nature Medicine 2: 545–550.
van Herrath M, Oldstone MBA and Fox HS (1995) Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus. J. Immunology 154: 5582–5589.
Warnes A and Fooks AR (1996) Live Viral Vectors: Construction of a replication deficient recombinant adenovirus. In: A Robinson, G Farrar and C Wiblin (eds) Methods in Molecular Medicine, Vaccine Protocols Series, 33–45, Humana Press, NJ, USA.
Wilkinson GWG (1994) Gene therapy and viral vaccination. Revs. Med. Micro. 5: 97–106.
Wilkinson GWG and Akrigg A (1992) Constitutive and enhanced expression from the CMV major IE promoter in a replication defective adenovirus vector. Nucleic Acid Research 20: 2235–2239.
Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E and Wilson JM (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91: 4407–4411.
Rights and permissions
About this article
Cite this article
Sivasubramaniam, S., Fooks, A., Lee, J. et al. Gene delivery into neuronal and glial cells by using a replication-deficient adenovirus vector: prospects for neurological gene therapy. Cytotechnology 24, 253–259 (1997). https://doi.org/10.1023/A:1007904429698
Issue Date:
DOI: https://doi.org/10.1023/A:1007904429698